Tesla Joins Court Challenges to EU Tariffs on Chinese EVs

16 June 2015, Ebringen: The logo of Tesla electric vehicle company is pictured on an S model vehicle. (dpa)
16 June 2015, Ebringen: The logo of Tesla electric vehicle company is pictured on an S model vehicle. (dpa)
TT

Tesla Joins Court Challenges to EU Tariffs on Chinese EVs

16 June 2015, Ebringen: The logo of Tesla electric vehicle company is pictured on an S model vehicle. (dpa)
16 June 2015, Ebringen: The logo of Tesla electric vehicle company is pictured on an S model vehicle. (dpa)

Tesla has joined BMW and Chinese producers in filing a challenge at the Court of Justice of the European Union (CJEU) against EU tariffs on China-made electric vehicles, according to a filing on the court's website on Monday.

The challenge will open a new front in Brussels' conflict with Elon Musk, Tesla CEO and ally of US President Donald Trump. Earlier this month, the EU stepped up its probe into Musk's social media platform X over content moderation, Reuters reported.

The EU imposed tariffs on China-made EVs at the end of October after an anti-subsidy investigation. The rate for Tesla was 7.8%, lower than any of its competitors.

The court document showed the US automaker lodged its complaint at the General Court, the lower of two CJEU chambers, last Wednesday, the deadline for filing challenges. Proceedings at the General Court last on average 18 months and can be appealed.

No further details of the cases were given.

BMW, Chinese electric vehicle makers BYD, Geely and SAIC, and auto sector body CCCME have also challenged the EU's import tariffs at the court.



AI Can Identify Women at Risk of Breast Cancer Years in Advance, Study Finds

Visitors walk past a sculpture of a pink ribbon installed to promote the "Pink Ribbon" breast cancer awareness campaign in this illustration, October 5, 2011. (Reuters)
Visitors walk past a sculpture of a pink ribbon installed to promote the "Pink Ribbon" breast cancer awareness campaign in this illustration, October 5, 2011. (Reuters)
TT

AI Can Identify Women at Risk of Breast Cancer Years in Advance, Study Finds

Visitors walk past a sculpture of a pink ribbon installed to promote the "Pink Ribbon" breast cancer awareness campaign in this illustration, October 5, 2011. (Reuters)
Visitors walk past a sculpture of a pink ribbon installed to promote the "Pink Ribbon" breast cancer awareness campaign in this illustration, October 5, 2011. (Reuters)

Artificial intelligence is able to identify women who have an elevated risk of developing breast cancer several years before it is diagnosed, the Norwegian Institute of Public Health (FHI) said on Tuesday.

Five researchers from FHI, the University of California and the University of Washington were given access to a commercially available AI program to retroactively analyze the mammographies of 116,495 women who took part in a Norwegian detection program between 2004 and 2018.

In total, 1,607 of the women developed breast cancer.

The algorithm was able to predict which women ran a higher risk of developing breast cancer, and even identify which breast was at risk, four to six years before a diagnosis.

"We noted that the breast which developed cancer had an AI score about twice as high as the other breast," said Solveig Hofvind, who heads the detection program and the AI project.

"The study shows that the AI algorithms already available on the market can be used to develop more personalized detection programs," she said.

AI could be used for early detection of breast cancer, to reduce costs and better target at-risk populations, FHI said.

According to the World Health Organization, 670,000 women died of breast cancer in 2022, the most common form of cancer among women in most countries.

The study is published in the Journal of the American Medical Association Network, which edits a collection of prestigious medical journals.

The Norwegian detection program also launched a project last year involving 140,000 women to determine whether AI could be as efficient as, or even better than, radiologists to diagnose cancer cases.